Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

6.66
-0.0350-0.52%
Volume:10.97K
Turnover:74.16K
Market Cap:3.82M
PE:-0.07
High:7.04
Open:6.92
Low:6.53
Close:6.70
52wk High:80.10
52wk Low:2.98
Shares:573.24K
Float Shares:485.10K
Volume Ratio:0.18
T/O Rate:2.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.0714
EPS(LYR):-98.0714
ROE:-178.39%
ROA:-60.68%
PB:0.90
PE(LYR):-0.07

Loading ...

SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination

TIPRANKS
·
Yesterday

Scisparc: Neurothera-Clearmind Collaboration Advances Mdma-N-Acylethanolamines Ip for the Treatment of Ptsd Amid Rising U.S. Federal Support for Psychedelic Innovation

THOMSON REUTERS
·
Yesterday

Scisparc Posts Audited 2025 Net Loss of USD 12.56 Million

Reuters
·
Aug 19

Scisparc: Subsidiary Neurothera Labs Completes C$5.4 Million Financing with Scisparc’s Stake Valued at Approximately C$30 Million

THOMSON REUTERS
·
Aug 18

NeuroThera Labs Raises C$ 2.7 Million in First Tranche of Non-Brokered Private Placement at C$ 0.12 Per Unit

Reuters
·
Aug 13

SciSparc Unit NeuroThera Labs Wins Japanese Patent for Paracetamol Combination Therapy

Reuters
·
Aug 12

Scisparc’s Subsidiary Neurothera Labs Granted Japanese Patent for Its Proprietary, Innovative Therapeutic Combination

THOMSON REUTERS
·
Aug 12

SciSparc Subsidiary NeuroThera Launches Phase IIb Tourette Trial Site at Yale Child Study Center

Reuters
·
Aug 05

Scisparc: Subsidiary Neurothera Labs Launches Phase Iib Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome

THOMSON REUTERS
·
Aug 05

SciSparc Subsidiary NeuroThera Labs’ Quantum Platform Completes End-to-end Hybrid Workflow for Clinical Data Analytics

Reuters
·
Jul 31

NASDAQ Trade Halt Volatility Trading Pause at 10:22 Am

Reuters
·
Jul 29

Scisparc Ltd trading halted, volatility trading pause

TIPRANKS
·
Jul 29

SciSparc Targets Agentic AI Market as New Growth Strategy

Reuters
·
Jul 29

SciSparc Subsidiary NeuroThera Labs Validates Quantum Sampling Workflow for Clinical Trials Analytics Platform

Reuters
·
Jul 29

Scisparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

THOMSON REUTERS
·
Jul 27

Scisparc - in Discussions with Companies in Agentic AI Field

THOMSON REUTERS
·
Jul 27

SciSparc initiates SCI-110 clinical trial in Germany

TIPRANKS
·
Jul 15

Scisparc: Neurothera Labs Announces Initiation of Phase Iib Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

THOMSON REUTERS
·
Jul 15

Scisparc Unit Neurothera Labs Starts Phase Iib Tourette Trial Site at Hannover Medical School

Reuters
·
Jul 15

Neurothera Labs Targets up to C$ 5 Million in Private Placement of Units at C$ 0.135 Each

Reuters
·
Jul 01